ATI RN
ATI Pharmacology Quiz 25E Questions
Extract:
Question 1 of 5
The patient is receiving enoxaparin (Lovenox) subcutaneously every 12 hours following knee replacement surgery. The patient is monitored for.
Correct Answer: D
Rationale: The correct answer is D: Signs and symptoms of bruising and bleeding. Enoxaparin is an anticoagulant that helps prevent blood clots. Monitoring for bruising and bleeding is crucial due to the increased risk of bleeding associated with anticoagulant therapy. Clotting at the incision site (
A) is not expected as enoxaparin prevents clot formation. Increased pain (
B) and gingival hyperplasia (
C) are not commonly associated with enoxaparin therapy. Monitoring for signs and symptoms of bruising and bleeding allows for early detection of any potential complications.
Question 2 of 5
Correct Answer:
Rationale:
Question 3 of 5
Correct Answer:
Rationale:
Question 4 of 5
Correct Answer:
Rationale:
Question 5 of 5
Correct Answer:
Rationale: